[PR Newswire] – INDIANAPOLIS, Feb. 12, 2014 /PRNewswire/ — Lilly USA, LLC (LLY) announced today the launch of a new rotation program for aspiring physicians. The rotation assignments cut across different aspects of the pharmaceutical company’s business moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, […]
moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]
moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]
[at noodls] – Arrangement to facilitate future collaborations in personalized medicine Provides framework to develop and commercialize QIAGEN companion diagnostics paired with Lilly medicines in an effort to improve … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]
moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]
[at noodls] – Date: January 15, 2013 For Release: Immediately Refer to: Celeste Stanley, + 317-478-0263 (mobile), [email protected] Amyvid (Florbetapir (18F)) Solution for Injection Approved in European Union … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]
[at noodls] – Date: December 17, 2012 For Release: Immediately Refer to: (317) 276-5795 – Mark Taylor (media) (317) 655-6874 – Phil Johnson (investors) Lilly Sets Dates and Conference Calls for 2013 Financial Guidance … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to […]
[ACN Newswire] – By David MoskowitzShares of Endo Pharmaceuticals (NASDAQ:ENDP) are trading at a deep discount to other pharmaceutical companies, with the last dip in price coming on the heels of guidance at the company’s … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingDespite a stash of cash and liquid investments, Lexicon Pharmaceuticals (NASDAQ:LXRX) caught investors off guard two weeks ago by initiating a capital raise. The company had more than $225M … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingTwo pertinent announcements from Lexicon Pharmaceuticals (NASDAQ:LXRX) are giving shares a 7% lift on Friday morning. The company reported top-line data from the latest Phase II trial of telotristat … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboard […]
